We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves New Drugs Faster Than Five International Agencies
The item has been added to your shopping cart.
FDA Approves New Drugs Faster Than Five International Agencies
The increased use of fast track regulatory pathways has led to the FDA having the shortest median approval time for new active drug substances in 2017 compared to five other international regulatory agencies, according to the UK-based Centre for Innovation in Regulatory Science (CIRS).
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor